Earnings History Data for Freeline Therapeutics Holdings plc (FRLN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Freeline Therapeutics Holdings plc

Freeline Therapeutics Holdings plc is a clinical-stage biotechnology company. It is focused on AAV-based gene therapy targeting the liver. The company operates principally in Germany and the U.S. Freeline Therapeutics Holdings plc is headquartered in the U.K.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
15-08-2023	PM		FRLN	Freeline Therapeutics Holdings plc	17.71	-0.21	-3.62	-4.78	Freeline Therapeutics GAAP EPS of -$0.23 beats by $3.28, revenue of $0.62M [8/15/2023 7:02 AM]	3.89	-0.21 (-5.12%)	0.0	0.0 (0.00%)	2.11 - 14.84	29,990	90,000	0
Freeline Therapeutics GAAP EPS of -$0.23 beats by $3.28, revenue of $0.62M [8/15/2023 7:02 AM]
04-04-2023	PM	7:00 AM ET (Apr 4)	FRLN	Freeline Therapeutics Holdings plc	33.46	-0.35	-0.34	-0.97	Freeline Therapeutics GAAP EPS of -$1.50 beats by $0.28 [4/4/2023 7:02 AM]	0.4623	-0.01 (-1.66%)	0.46	-0.02 (-3.19%)	0.39 - 1.18	38,541	40,000	16,248
Freeline Therapeutics GAAP EPS of -$1.50 beats by $0.28 [4/4/2023 7:02 AM] Freeline, Forcefield team up to develop gene therapies for heart diseases [4/4/2023 7:46 AM]
09-08-2022	PM	0:00 AM ET (Aug 9)	FRLN	Freeline Therapeutics	54.00	-0.32	-0.54	0.00	Freeline Therapeutics GAAP EPS of -$0.95 misses by $0.44 [8/9/2022 8:37 AM]	0.9126	0.06 (7.24%)	0.85	0.0 (0.14%)	0.65 - 4.90	91,945	70,000	5,064
Freeline Therapeutics GAAP EPS of -$0.95 misses by $0.44 [8/9/2022 8:37 AM] Freeline Reports Second Quarter 2022 Financial Results and Business Highlights [Aug-09-22 07:00AM] 5 Biotech Stocks Likely to Outpace Q2 Earnings Estimates [Aug-09-22 07:40AM]
10-05-2022	AH		FRLN	Freeline Therapeutics	29.00	-0.63	-0.58	0.00	Freeline Therapeutics GAAP EPS of -$0.63 [5/10/2022 5:48 PM]	0.6830	-0.02 (-3.18%)	0.71	0.0 (0.65%)	0.65 - 15.40	51,048	130,000	4,691
Freeline Therapeutics GAAP EPS of -$0.63 [5/10/2022 5:48 PM] Freeline Reports First Quarter 2022 Financial Results and Business Highlights [May-10-22 04:01PM]
31-03-2022	AH		FRLN	Freeline Therapeutics Holdings plc	71.14	-0.97	-0.72	0.00	Freeline Therapeutics GAAP EPS of -$3.93 [3/31/2022 5:09 PM]	1.09	-0.03 (-2.54%)	1.09	-0.03 (-2.68%)	0.91 - 15.40	95,293	510,000	8,875
Freeline Therapeutics GAAP EPS of -$3.93 [3/31/2022 5:09 PM] Freeline Reports Full Year 2021 Financial Results and Business Highlights [Mar-31-22 04:01PM]